Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: Comparing treatment with risperidone and haloperidol

No abstract is available for this paper.

• Publication year

  2012

• Venue

  World Journal of Biological Psychiatry

• Publication date

  2012-01-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.3109/15622975.2011.552633PMID 21568628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• R: A language and environment for statistical computing.

  2014cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia

  2010cited by this paper
• Atypical antipsychotics for people with both schizophrenia and depression.

  2009cited by this paper
• Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.

  2008cited by this paper
• Drug Treatment of Depressive Symptoms in Schizophrenia

  2008cited by this paper
• Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.

  2008cited by this paper
• Depression in schizophrenia: comparison of first- and second-generation antipsychotic drugs.

  2008cited by this paper
• Atypical antipsychotics for people with both schizophrenia and depression.

  2008cited by this paper
• Associations of multiple domains of self-esteem with four dimensions of stigma in schizophrenia.

  2008cited by this paper
• Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.

  2008cited by this paper
• Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

  2007cited by this paper
• Defining ‘Response’ in Antipsychotic Drug Trials: Recommendations for the Use of Scale-Derived Cutoffs

  2007cited by this paper
• How clinical diagnosis might exacerbate the stigma of mental illness.

  2007cited by this paper
• Remission in first-episode psychosis: predictor variables and symptom improvement patterns.

  2006cited by this paper
• Remission in schizophrenia: proposed criteria and rationale for consensus.

  2005cited by this paper
• The evolution of insight, paranoia and depression during early schizophrenia

  2004cited by this paper
• An exploratory analysis of correlates of recovery.

  2004cited by this paper
• Depression in Kraepelinian schizophrenia.

  2003cited by this paper
• Depressive symptoms at baseline predict fewer negative symptoms at follow-up in patients with first-episode schizophrenia.

  2002influential reference
• Typical antipsychotic drugs -- D(2) receptor occupancy and depressive symptoms in schizophrenia.

  2002cited by this paper
• Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidone.

  2002cited by this paper
• Depressive, Positive, Negative and Parkinsonian Symptoms in Schizophrenia

  2001cited by this paper
• Depression in patients with schizophrenia during an acute psychotic episode.

  2001cited by this paper
• Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents.

  2000cited by this paper
• Prevalence and background factorsof depression in first admittedschizophrenic patients

  2000cited by this paper
• Depressive symptoms in stable chronic schizophrenia: prevalence and relationship to psychopathology and treatment.

  2000cited by this paper
• Depressive symptoms in schizophrenia.

  1999cited by this paper
• Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?

  1999cited by this paper
• Depression in people with first-episode schizophrenia

  1998cited by this paper
• [Conceptual aspects in development and implementation of basic psychiatric documentation].

  1998cited by this paper
• Psychological sequelae of torture and organised violence suffered by refugees from Iraq

  1998cited by this paper
• A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.

  1996cited by this paper
• Depression in first-episode schizophrenia.

  1993cited by this paper
• Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis

  1993cited by this paper
• Akinesia: a syndrome common to parkinsonism, retarded depression, and negative symptoms of schizophrenia.

  1992cited by this paper
• Suicide and schizophrenia: data from a prospective community treatment study.

  1990cited by this paper
• UNIX: The Minimal Manual

  1990cited by this paper
• Abnormal Involuntary Movement Scale (AIMS).

  1988influential reference
• Depressive symptoms in schizophrenia: comprehensive differential diagnosis.

  1988cited by this paper
• Reliability and validity of the positive and negative syndrome scale for schizophrenics.

  1988cited by this paper
• Prodromal symptoms and prevention of relapse in schizophrenia.

  1985cited by this paper
• A class of rank test procedures for censored survival data

  1982cited by this paper
• Studies of Depressive Symptoms in Schizophrenia

  1981cited by this paper
• Postpsychotic depression in schizophrenia.

  1976cited by this paper
• Development of a rating scale for primary depressive illness.

  1967cited by this paper

• Depressive symptomatology in the first-episode schizophrenia spectrum disorders OPTiMiSE trial: prevalence, correlates, symptom progression and outcomes

  2025cites this paper
• [Melatonergic antidepressant agomelatine: augmentation of antipsychotic drugs in treatment of post-schizophrenic depression].

  2024cites this paper
• Meta-Analysis of the Efficacy of Risperidone Treatment in Patients with First-Episode Schizophrenia.

  2024cites this paper
• Delusional beliefs in adolescents with anorexia nervosa, obsessive-compulsive disorder, or first-episode psychosis: A comparative study.

  2023cites this paper
• Inflammatory markers of symptomatic remission at 6 months in patients with first-episode schizophrenia

  2023cites this paper
• Association between depression in chronic phase and future clinical outcome of patients with schizophrenia

  2022cites this paper
• Treatment of post-psychotic depression in first-episode psychosis. A systematic review

  2022cites this paper
• Suicidal behaviour after first-episode psychosis: results from a 1-year longitudinal study in Portugal

  2021cites this paper
• Pharmacological strategies for the management of comorbid depression and schizophrenia

  2020cites this paper
• Diagnosis and treatment depression in schizophrenia

  2020cites this paper
• Metabolic profiling identifies TC and LDL as potential serum biomarkers for depressive symptoms in schizophrenia.

  2019cites this paper
• Predictors of remission during acute treatment of first‐episode schizophrenia patients involuntarily hospitalized and treated with algorithm‐based pharmacotherapy: Secondary analysis of an observational study

  2019cites this paper
• The association of clinical insight and depression with quality of life in schizophrenia.

  2019cites this paper
• Haloperidol discontinuation for people with schizophrenia.

  2019cites this paper
• Predictors of treatment satisfaction in antipsychotic-naïve and previously medicated patients with acute-phase psychosis

  2019cites this paper
• Depressive psychopathology in first-episode schizophrenia spectrum disorders: a systematic review, meta-analysis and meta-regression

  2019cites this paper
• Cognitive behavior therapy in early psychosis with a focus on depression and low self-esteem: A randomized controlled trial.

  2019cites this paper
• Using early antipsychotic response to predict treatment outcome in patients with first-episode psychosis

  2016influential citation
• The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine.

  2016cites this paper
• Depressive symptoms in first‐episode psychosis: a 10‐year follow‐up study

  2016cites this paper
• Is good insight associated with depression among patients with schizophrenia? Systematic review and meta-analysis.

  2015cites this paper
• Rate and risk factors of depressive symptoms in Chinese patients presenting with first-episode non-affective psychosis in Hong Kong.

  2015influential citation
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation

  2015cites this paper
• Subclinical Depressive Symptoms and Continued Cannabis Use: Predictors of Negative Outcomes in First Episode Psychosis

  2015cites this paper
• Aktuelle Publikationen von Mitarbeitern oder unter Beteiligung von Mitarbeitern der Klinik und Poliklinik für Psychiatrie und Psychotherapie im Jahr 2014 Articles, Editorial Material, Letters, News Items, Notes und Reviews

  2014cites this paper
• Depressive symptoms in first episode psychosis: a one-year follow-up study

  2013influential citation